Can primary aldosteronism cause orthostatic hypotension?

Primary Aldosteronism Does NOT Typically Cause Orthostatic Hypotension

Primary aldosteronism (PA) characteristically causes hypertension through sodium retention and volume expansion, not orthostatic hypotension. The pathophysiology of PA—with autonomous aldosterone hypersecretion leading to sodium and water retention—produces the opposite hemodynamic effect of what would cause orthostatic hypotension 1, 2, 3.

Pathophysiologic Reasoning

PA induces:

• Intravascular volume expansion from sodium and water retention
• Suppressed plasma renin activity
• Sustained hypertension (often resistant to treatment)
• Increased cardiovascular damage independent of blood pressure elevation 1, 2

This volume-expanded state is fundamentally incompatible with orthostatic hypotension, which requires either volume depletion, autonomic dysfunction, or impaired vasoconstriction.

The Rare Exception: Coexisting Conditions

The only documented association between PA and orthostatic hypotension occurs when two separate pathologic conditions coexist—not when PA causes orthostatic hypotension. One case report described a patient with both an aldosterone-secreting adenoma AND chronic idiopathic orthostatic hypotension (dysautonomic failure), representing "the challenging association of 2 extreme conditions" 4. This was notable precisely because it was paradoxical and unprecedented.

Clinical Presentation of PA

PA typically presents with:

• Resistant hypertension (present in 20% of resistant hypertension cases) 2, 5
• Hypokalemia (though absent in majority of cases) 1, 2
• Supine hypertension when autonomic dysfunction coexists 6
• Increased cardiovascular complications: 2.8-fold increased stroke risk, 4.0-fold increased atrial fibrillation risk, 2.0-fold increased heart failure risk 2

Important Clinical Pitfall

If you encounter a patient with apparent PA who develops orthostatic hypotension, consider:

1. Overtreatment with mineralocorticoid receptor antagonists (spironolactone/eplerenone) causing volume depletion
2. Coexisting autonomic neuropathy (particularly in diabetic patients) 6
3. Separate dysautonomic disorder requiring independent evaluation 4
4. Medication effects from other antihypertensive agents

The presence of orthostatic hypotension should prompt reconsideration of the diagnosis or investigation for additional pathology rather than being attributed to PA itself.